Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
R03BB Anticholinergics
R03BB05 Aclidinium bromide
D08837 Aclidinium bromide (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Bronchodilators, Anticholinergic
Aclidinium
D08837 Aclidinium bromide (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
22 Respiratory organ agents
225 Bronchodilators
2259 Others
D08837 Aclidinium bromide (JAN/USAN/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
D08837 Aclidinium bromide
Metabolizing enzyme substrate
DG02973 BCHE substrate
D08837 Aclidinium bromide
Metabolizing enzyme inhibitor
DG01645 CYP2D6 inhibitor
D08837 Aclidinium bromide
DG02852 CYP3A/CYP3A4 inhibitor
DG01522 CYP3A4 inhibitor
D08837 Aclidinium bromide
DG01915 CYP3A5 inhibitor
D08837 Aclidinium bromide
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM
D08837 Aclidinium bromide (JAN/USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D08837
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D08837
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D08837
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D08837
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D08837